Arix Bioscience

Arix Bioscience, a research and development services company based in GB, is committed to achieving Net-Zero status by 2050 or sooner. This ambitious long-term target involves reducing over 90% of its emissions.

For its reporting year 2022, Arix Bioscience reported total absolute emissions of approximately 13,300 kg CO2e. This figure comprises:

• Scope 1 emissions: Approximately 3,680 kg CO2e.
• Scope 2 emissions: Approximately 4,410 kg CO2e (market-based) or 8,100 kg CO2e (location-based).
• Scope 3 emissions: Approximately 5,210 kg CO2e.

In the previous year, 2021, total emissions were approximately 10,430 kg CO2e, broken down as:

• Scope 1 emissions: Approximately 4,860 kg CO2e.
• Scope 2 emissions: Approximately 2,670 kg CO2e (market-based) or 7,530 kg CO2e (location-based).
• Scope 3 emissions: Approximately 2,900 kg CO2e.

In 2020, Arix Bioscience's Scope 1 emissions were approximately 5,020 kg CO2e, and Scope 2 emissions were approximately 6,770 kg CO2e (market-based) or 11,800 kg CO2e (location-based). Scope 3 emissions were not disclosed for this year.

Arix Bioscience has also set a near-term intensity reduction target: a 40% reduction in carbon emissions by 2025 compared to a 2019 baseline, normalised to occupied areas.

The company's emissions data is not cascaded from a parent organisation; it is reported directly.